CureMatch Articles & News
Oncology is currently the largest area of clinical health expenditures for prescription drugs in the United States [1], and, based on the current pace of innovation in cancer care, anti-cancer treatment costs are only expected to increase [2]. Still, cancer remains a significant medical challenge, stubbornly resistant to conventional treatments. Further, many patients with cancer […]
Navid Alipour, founder of our parent company, Analytics Ventures, was interviewed by AI Trends regarding the challenges of using artificial intelligence in healthcare–and how we at CureMatch are working to solve those challenges. Read the full article here.
CureMatch is pleased to announce our win at MedTech Insight Awards 2019 in the category of Best Technological Innovation: Digital. The judges explained their choice by describing the platform as “An exciting technology that has the potential to transform how cancer care is delivered. What an excellent use of data, and a well-deserved winning entry […]
CureMatch is pleased to announce our recent nomination for two innovation awards. MedTech announced that CureMatch is nominated for Best Technological Innovation: Diagnostics and Best Technological Innovation: Digital in their 2019 Insight Awards. The award ceremony will be held September 23 in Boston, Massachusetts, during the MedTech conference, hosted by AdvaMed. This valuable annual conference […]
SAN DIEGO, CA – July 22, 2019 – CureMatch is pleased to announce the hire of Yekaterina Khotskaya as vice president of clinical operations. As head of CureMatch’s clinical operations, Dr. Khotskaya will bring her experience in research, software development, project management, and molecular diagnostics to work hand in hand with clinicians to bring CureMatch’s […]